Concepedia

Xueling Hu

XH

Statistics

Publications

13

Citations

502

H-Index

12

Active since

2015

Affiliations

Harbin Medical University(Current)

Kanion Pharmaceutical (China)

Jinan University

Heilongjiang Academy of Sciences

Zhejiang Chinese Medical University

Xueling Hu is an author at Harbin Medical University specializing in life sciences, pharmacology, and microrna biology.

Publications per year

2015–2024

13

Publications

13

Long non-coding RNA CCRR controls cardiac conduction via regulating intercellular coupling

Yong Zhang, Lihua Sun, Lina Xuan et al. · Nature Communications · 2018 · 94 citations · Full text

, , +16

Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis

Yu Bian, Xin Li, Ping Pang et al. · Acta Pharmacologica Sinica · 2019 · 86 citations · Full text

, , +10

Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves micro<scp>RNA</scp>‐195 down‐regulation

Lihua Sun, Tao Ban, Chengdi Liu et al. · Journal of Neurochemistry · 2015 · 78 citations

, , +14

Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway

Xin Li, Xueling Hu, Tengfei Pan et al. · Biomedicine & Pharmacotherapy · 2020 · 52 citations · Full text

, , +16

Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy

Qiuning Wang, Xuefeng Yang, Ying Song et al. · Life Sciences · 2021 · 32 citations

, , +10

1–5 of 13